LIN28 can also regulate the processing of miR-638, thus inhibiting its maturation and promoting VASP expression, while CREB1, as a transcription factor, binds to the promoter of LIN28 gene and activates the LIN28/miR-638/VASP pathway, which promotes the proliferation and migration of breast cancer cells. This evidence concerns the gene LIN28A and breast carcinoma.